Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1981 1
1991 2
1999 1
2000 3
2001 1
2003 2
2005 2
2006 5
2007 4
2008 6
2009 5
2010 5
2011 5
2012 3
2013 4
2014 3
2015 2
2016 2
2019 4
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
GPR30: A G protein-coupled receptor for estrogen.
Prossnitz ER, Arterburn JB, Sklar LA. Prossnitz ER, et al. Among authors: arterburn jb. Mol Cell Endocrinol. 2007 Feb;265-266:138-42. doi: 10.1016/j.mce.2006.12.010. Epub 2007 Jan 11. Mol Cell Endocrinol. 2007. PMID: 17222505 Free PMC article. Review.
The ins and outs of GPR30: a transmembrane estrogen receptor.
Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB. Prossnitz ER, et al. Among authors: arterburn jb. J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):350-3. doi: 10.1016/j.jsbmb.2008.03.006. Epub 2008 Mar 6. J Steroid Biochem Mol Biol. 2008. PMID: 18406603 Free PMC article. Review.
Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects.
Mulrow C, Lawrence V, Ackermann R, Gilbert Ramirez G, Morbidoni L, Aguilar C, Arterburn J, Block E, Chiquette E, Gardener C, Harris M, Heidenreich P, Mullins D, Richardson M, Russell N, Vickers A, Young V. Mulrow C, et al. Among authors: arterburn j. Evid Rep Technol Assess (Summ). 2000 Oct;(20):1-4. Evid Rep Technol Assess (Summ). 2000. PMID: 11089496 Free PMC article. Review. No abstract available.
64 results